About Us
Enlyte News
There’s always something going on at Enlyte. Stay up to date with the latest developments.
Prescribing Care: How Risk Management Can Support Health Care Workers
Dawn Moore, RN, senior director, case management services, explains how increasing stressors in health care are factoring into more providers leaving the field. And, as more providers leave, those who stay in the field often must work longer hours, exacerbating the situation.
Push Continues To Expand Cancer Presumptions For Firefighters
Brian Allen was recently featured among top regulatory professionals in a Business Insurance article focusing on the increase of cancer presumption regulations in state workers’ comp systems.
Enlyte and Emperion Finalize Creation of Stand-Alone IME Business
Emperion and Enlyte leaders have completed the separation of IME, Peer Review (PR), and Independent Review Organization (IRO) services from Enlyte to Emperion, following the agreement announced in February. Emperion will focus on expanded product development and investment opportunities for these and related solutions, paving the way for specialized IME and Peer Review growth and innovation.
Medical costs for injured workers outpaced overall cost increases nationwide
Business Insurance recently featured an insightful piece on Enlyte's latest quarterly medical price index report.
Latest Mitchell Data Shows Continued Increase in Electric Vehicle Collision Claims
Mitchell today announced the publication of its latest trends report: Plugged-In: EV Collision Insights. This issue provides a year-over-year analysis of EV claims volume, which increased in 2023 by more than 40% in the U.S. and Canada.
Rising PTSD claims, wider comp liabilities spotlight importance of treatment guidelines
Mental health experts say that adherence to guidelines for the diagnosis and treatment of PTSD is essential when treating affected workers.
Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc. Emperion will be owned by Stone Point Capital, Enlyte’s current shareholder, through its Trident Funds and a management team led by former Genex executives.
See the P&C Industry From Our 360-Degree Vantage Point
In an ever-changing landscape, trusted knowledge is like gold. We’re the insiders you can count on to break down the opportunities and challenges facing the industry today, with the expertise to share actionable insights.
